CHINA RE (01508): China Re Life Insurance reported a net loss of 251 million yuan in the first quarter.
China Reinsurance (01508) announced that its subsidiary, China Life Reinsurance Limited (China Re Life), achieved operating income of RMB 2.479 billion and a net loss of RMB 0.251 billion for the three months ended March 31, 2026.
CHINA RE (01508) announced that its subsidiary, China Life Insurance Reinsurance Co., Ltd. (China Life Reinsurance), achieved operating revenue of RMB 2.479 billion for the three months ending on March 31, 2026, with a net loss of RMB 0.251 billion.
Related Articles
J&T EXPRESS-W (01519) spent 23.4103 million Hong Kong dollars to repurchase 2.284 million shares on April 28th.
UNITED LAB (03933): TUL321 Capsules receive approval for new drug clinical trials by the US FDA.
LEGENDHOLDING (03396) will distribute a final dividend of 0.1 yuan per share on August 28th.
J&T EXPRESS-W (01519) spent 23.4103 million Hong Kong dollars to repurchase 2.284 million shares on April 28th.
UNITED LAB (03933): TUL321 Capsules receive approval for new drug clinical trials by the US FDA.
LEGENDHOLDING (03396) will distribute a final dividend of 0.1 yuan per share on August 28th.
